Sunshine Biopharma Inc. Gain (Loss) on Extinguishment of Debt
Sunshine Biopharma Inc. (SBFM) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2024-03-28
- Sunshine Biopharma Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-12-31 was $0.00.
- Sunshine Biopharma Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-09-30 was $0.00.
- Sunshine Biopharma Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-03-31 was $0.00.
- Sunshine Biopharma Inc. gain (loss) on extinguishment of debt for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Sunshine Biopharma Inc. gain (loss) on extinguishment of debt for fiscal 2022 was $10.85K, a 78.73% decline from fiscal 2021.
- Sunshine Biopharma Inc. gain (loss) on extinguishment of debt for fiscal 2021 was $51.03K, a 564.99% increase from fiscal 2020.
- Sunshine Biopharma Inc. gain (loss) on extinguishment of debt for fiscal 2020 was $7.67K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 3 month as first filed | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 6 month as first filed | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 | ||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | $0.00 derived: sum of 4 quarters · filed 2024-03-28 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $0.00 derived: sum of 4 quarters · filed 2024-03-28 | ||
| 2023-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $10.85K derived: sum of 4 quarters · filed 2024-03-28 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $10.85K derived: sum of 3 quarters · filed 2024-03-28 | $10.85K 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | $10.85K derived: sum of 2 quarters · filed 2023-11-13 | $10.85K 10-Q · filed 2023-11-13 | $2.94K derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $10.85K 10-Q · filed 2023-08-10 | $10.85K 10-Q · filed 2023-08-10 | $2.94K derived: sum of 3 quarters · filed 2023-08-10 | $10.63K derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-06 | -$7.91K derived: sum of 2 quarters · filed 2022-05-06 | -$221.00 derived: sum of 3 quarters · filed 2022-11-07 | $0.00 derived: sum of 4 quarters · filed 2022-11-07 | ||
| 2021-12-31 | -$7.91K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | -$221.00 derived: sum of 2 quarters · filed 2022-11-07 | $0.00 derived: sum of 3 quarters · filed 2022-11-07 | $51.03K 10-K · filed 2022-03-21 | ||
| 2021-09-30 | $7.69K 10-Q · filed 2022-11-07 | $7.91K derived: sum of 2 quarters · filed 2022-11-07 | $58.94K 10-Q · filed 2022-11-07 | $63.78K derived: sum of 4 quarters · filed 2022-11-07 | ||
| 2021-06-30 | $221.00 10-Q · filed 2022-08-03 | $51.25K 10-Q · filed 2022-08-03 | $56.09K derived: sum of 3 quarters · filed 2022-08-03 | $57.37K derived: sum of 4 quarters · filed 2022-08-03 | ||
| 2021-03-31 | $51.03K 10-Q · filed 2022-05-06 | $55.87K derived: sum of 2 quarters · filed 2022-05-06 | $57.15K derived: sum of 3 quarters · filed 2022-05-06 | $58.41K derived: sum of 4 quarters · filed 2022-05-06 | ||
| 2020-12-31 | $4.84K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $6.12K derived: sum of 2 quarters · filed 2022-03-21 | $7.38K derived: sum of 3 quarters · filed 2022-03-21 | $7.67K 10-K · filed 2022-03-21 | ||
| 2020-09-30 | $1.28K 10-Q · filed 2021-11-09 | $2.54K derived: sum of 2 quarters · filed 2021-11-09 | $2.84K 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | $1.26K 10-Q · filed 2021-08-09 | $9.51K 10-Q · filed 2020-08-19 | $1.55K 10-Q · filed 2021-08-09 | $9.80K 10-Q · filed 2020-08-19 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-11 | |||||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | |||
| 2019-06-30 | $0.00 10-Q/A · filed 2020-08-31 | $0.00 10-Q/A · filed 2020-08-31 | $720.00 10-Q · filed 2019-08-15 | |||
| 2018-06-30 | $247.00 10-Q · filed 2019-08-15 | |||||
| 2016-09-30 | $7.79K 10-Q · filed 2017-11-15 | $7.79K 10-Q · filed 2017-11-15 | ||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |